Multiple Epiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
One of the affected family members had a double-layered patella, which is frequently seen in patients with autosomal recessive MED caused by DTDST mutations and sporadically in the dominant form of MED caused by COL9A2 defect.
|
30740902 |
2019 |
Multiple Epiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Pathogenic sequence variants in the solute carrier family 26 member 2 (SLC26A2) gene result in lethal (achondrogenesis Ib and atelosteogenesis II) and non-lethal (diastrophic dysplasia and recessive multiple epiphyseal dysplasia, rMED) chondrodysplasias.
|
30423444 |
2019 |
Multiple Epiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The homozygous A2092T (T689S) mutation could be one of the mutations in the DTDST gene causing MED.
|
23934641 |
2014 |
Multiple Epiphyseal Dysplasia
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Pseudoachondroplasia and multiple epiphyseal dysplasia: a 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution.
|
21922596 |
2012 |
Multiple Epiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Six genes known to be associated with MED (COMP, MATN3, COL9A1, COL9A2, COL9A3, and DTDST) were screened by sequencing.
|
21965141 |
2011 |
Multiple Epiphyseal Dysplasia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Six genes involved in MED, COMP, MATN3, COL9A1, COL9A2, COL9A3, and DTDST have been identified; however, the presence of additional disease genes has been reported, and the detection rate for mutations in known genes accounts for no more than 50% of patients with MED in Western populations.
|
16691584 |
2006 |
Multiple Epiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the diastrophic dysplasia sulfate transporter (DTDST or SLC26A2) cause a family of recessively inherited chondrodysplasias including, in order of decreasing severity, achondrogenesis 1B, atelosteogenesis 2, diastrophic dysplasia (DTD) and recessive multiple epiphyseal dysplasia.
|
15703192 |
2005 |
Multiple Epiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Special interest has focused on four members of the SLC26 family that are associated with distinct recessive diseases: (i) Mutations in SLC26A2 lead to four different chondrodysplasias (diastrophic dysplasia, atelosteogenesis type II, achondrogenesis type IB and multiple epiphyseal dysplasia); (ii) SLC26A3 is associated with congenital chloride diarrhea; (iii) SLC26A4 is associated with Pendred syndrome and non-syndromic deafness, DFNB4; and (iv) SLC26A5 is defective in non-syndromic hearing impairment.
|
15720248 |
2005 |
Multiple Epiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene result in a family of skeletal dysplasias, which comprise lethal (achondrogenesis type 1B and atelosteogenesis type 2) and non-lethal conditions (diastrophic dysplasia and recessive multiple epiphyseal dysplasia (rMED)).
|
12966518 |
2003 |
Multiple Epiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
A homozygous R279W mutation was recently found in the diastrophic dysplasia sulfate transporter gene, DTDST, in a patient with MED who had a club foot and double-layered patella.
|
11565064 |
2001 |
Multiple Epiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the DTDST gene have recently been identified in a recessive form of MED.
|
11528506 |
2001 |
Multiple Epiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
A recessive form of MED (EDM4) has also been reported; it is caused by a mutation in the diastrophic dysplasia sulfate transporter gene (SLC26A).
|
11479597 |
2001 |
Multiple Epiphyseal Dysplasia
|
0.500 |
Biomarker
|
disease |
HPO |
|
|
|